Blood-based diagnosis and risk stratification of patients with pancreatic intraductal papillary mucinous neoplasm (IPMN).

Chaoyang Zhang Fawaz N Al-Shaheri Mohamed Saiel Saeed Alhamdani Andrea S Bauer Jörg D Hoheisel Miriam Schenk Ulf Hinz Philipp Goedecke Karam Al-Halabi Markus Wolfgang Büchler Nathalia A Giese Thilo Hackert Susanne Roth

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)

Protein and microRNA biomarkers in blood allow precise diagnosis and risk stratification of IPMN cases, which should improve patient management and thus the prognosis of IPMN patients.

Keyphrases

end stage renal disease
low grade
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
high grade
small molecule